FindTrial
Sign In

The effect of remimazolam besylate on delirium and the circulatory system in patients undergoing mechanical ventilation after surgery in the Surgical Intensive Care Unit: A prospective, randomized controlled study

The effect of remimazolam besylate on delirium and the circulatory system in patients undergoing mechanical ventilation after surgery in the Surgical Intensive Care Unit: A prospective, randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109184
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium and hemodynamic status in mechanically ventilated patients

Interventions

test group:Remifentanil + Remimazolam Benzenesulfonate
control group:Remifentanil + Dexmedetomidine

Sponsors

Guilin City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 75 years old; 2. Postoperative patients requiring invasive mechanical ventilation who can be maintained in a light sedation state (RASS -2 to 1); 3. Obtaining informed consent from the patient or their family.

Exclusion criteria

Exclusion criteria: 1. neurological dysfunction, mental illness, dementia, or individuals unable to communicate with medical staff due to language barriers; 2. patients with contraindications or allergies to study medication; 3. severe liver or kidney failure.

Design outcomes

Primary

MeasureTime frame
delirium incidence;—

Secondary

MeasureTime frame
hemodynamic indicators at each time point;Cardiac function indicators;—

Countries

China

Contacts

Public ContactHuang Wei

Guilin City People's Hospital

20964994@qq.com+86 189 7832 0050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026